EN DE
Watch RAGHUVIR SYNTHETICS LTD. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

RAGHUVIR SYNTHETICS LTD. (RAGHUSYN) fair value: what the stock is really worth

As of Oct 19, 2026: fair value (intrinsic value) of RAGHUVIR SYNTHETICS LTD. stock ₹8.36, price ₹65.50, upside -87.2%, quality 41 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Discretionary · IN · ISIN INE969C01022

RS RAGHUVIR SYNTHETICS LTD. logo Thin data Oct 4, 2026

RAGHUVIR SYNTHETICS LTD.

RAGHUSYN · BSE

Weakest SetupStrongly overvalued and low quality.

Our calculation puts a fair price 87% below what the stock costs today.

Quality 41/100
Expensive Growth (revenue 5y +8.1 %/yr in INR)
Moderate debt
Fair value ₹8.36 · Strongly overvalued (−87.2%)
Loss-making · -4.7% net margin (TTM)
Negative free cash flow
Trails peers (0/10)
Narrow moat 14/100 · thin data
Thin data
⚠ Small free float

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹977.65 ₹18.90 Fair Value ₹8.36 Jun 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.

How to read this chart

60‑month range ₹18.90 – ₹977.65 · fair‑value band ₹1.67 – ₹15.04 · the ₹65.50 price screens above the ₹8.36 fair value. Dashed = 300-day average. As of Oct 4, 2026.

Follow RAGHUVIR SYNTHETICS in your weekly email

Every Wednesday you see whether RAGHUVIR SYNTHETICS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Stock analysis

RAGHUVIR SYNTHETICS LTD. (RAGHUSYN) currently trades at ₹65.50, while our model-based Fair Value estimate is ₹8.36, 87.2% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: ₹1.67 (bear) to ₹15.04 (bull), the price of ₹65.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 41/100 (below-average quality), in the Consumer Discretionary sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

RAGHUVIR SYNTHETICS LTD. reported revenue of ₹2.6B in FY2026 versus ₹2.1B in FY2022, a compound +4.5%/yr. Reported net income was −₹12.8M in FY2026.

Key figures

Market cap ₹2.5B (≈ $26.5M) Micro · P/S ratio 1.46 · EPS (TTM) ₹−2.54 · Net margin −4.7% · Return on equity −3.7% · Return on assets (EBIT) 1.6% · Operating margin −8.7% · Revenue (TTM) ₹2.1B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 14 out of 100 (low confidence).

What moves the price

The share trades about 45% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Discretionary peers we cover trades at −25% fair-value upside, at −87%, RAGHUSYN screens richer than that median.

Fair Value models

Bear ₹1.67 Fair Value ₹8.36 Bull ₹15.04
Price ₹65.50 · Upside -87.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA ₹0.1300 ₹6.30 ₹12.47 57
NCAV (Graham) ₹4.38 ₹5.87 ₹8.76 54
All 2 models by family
Multiples
EV/EBITDA ₹0.1300 ₹6.30 ₹12.47 57
Asset-Based
NCAV (Graham) ₹4.38 ₹5.87 ₹8.76 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 41/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 41
How much profit the company makes from its sales and capital
Quality Growth 8
Are margins and returns getting better?
Cashflow 33
Do the profits arrive as real cash?
Financial strength 34
Debt, balance sheet and risk of trouble
Investment 62
Does it invest with discipline instead of growing at any price?
Low Volatility 64
How calm the share price moves, does not count
Momentum 8
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 24/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−23.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+39.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.1%
Start year 2021 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.0% (2021) → −0.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

RAGHUSYN screens overvalued: fair value 87% below the price. Compare with RAJPALAYAM →

Compare RAGHUVIR SYNTHETICS LTD. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textiles · 34 stocks

Beats the industry median on 0/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 41 · Bottom 25%
Fair Value upside −87.2% · Bottom 25%
Profitability
Return on assets −1.1% · Bottom 25%
Net margin (12 months) −4.7% · Bottom 25%
Operating margin (12 months) −8.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −56.4% · Bottom 25%
Balance sheet
Debt / equity 0.70× · Highest 25%

Valuation Multiplesvs Textiles median · lower = cheaper

P/B 7.39× · Priciest 25%
P/S (12 months) 1.20× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 5
FUTURE (revenue growth)0 · sector 0
PAST (return on equity)0 · sector 13
HEALTH (low debt)65 · sector 92
DIVIDEND (yield)0 · sector 6

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Textiles stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
RAJPALAYAM RAJPALAYAM ₹737.05 ₹1,586 +115% vs RAGHUSYN
SURYALA SURYALA ₹379.95 ₹687.59 +81% vs RAGHUSYN
RNBDENIMS RNBDENIMS ₹9.00 ₹15.60 +73% vs RAGHUSYN
PREMCO PREMCO ₹395.00 ₹307.99 −22% vs RAGHUSYN
TEXELIN TEXELIN ₹64.28 ₹48.44 −25% vs RAGHUSYN
VTMLTD VTMLTD ₹38.25 ₹22.16 −42% vs RAGHUSYN
ADDIND ADDIND ₹80.70 ₹36.98 −54% vs RAGHUSYN
CANDOUR CANDOUR ₹69.48 ₹20.30 −71% vs RAGHUSYN
LAKSHMIMIL LAKSHMIMIL ₹7,886 ₹1,326 −83% vs RAGHUSYN
OMNITEX OMNITEX ₹744.70 ₹120.81 −84% vs RAGHUSYN

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "RAGHUVIR SYNTHETICS LTD. Fair Value". https://www.fairvalue-calculator.com/stock/RAGHUSYN

Frequently asked questions

Is RAGHUVIR SYNTHETICS LTD. (RAGHUSYN) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of ₹8.36 versus a price of ₹65.50, about −87% upside (overvalued).
What is the fair value of RAGHUSYN?
Our model-based fair value for RAGHUVIR SYNTHETICS LTD. is ₹8.36 (as of Oct 4, 2026), built from audited fundamentals. The current price: ₹65.50.
What is the quality score of RAGHUSYN?
RAGHUVIR SYNTHETICS LTD. has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
Our model-based price target is the fair value of ₹8.36 (as of Oct 4, 2026) from 2 valuation models. Cautious scenario ₹1.67, optimistic scenario ₹15.04. It is a calculation from audited fundamentals, not an analyst target.
What is the RAGHUVIR SYNTHETICS LTD. stock forecast for 2026?
Our models put fair value at ₹8.36, about −87% upside versus a price of ₹65.50 (overvalued). Cautious scenario ₹1.67, optimistic scenario ₹15.04. The calculation is refreshed regularly with new filings.
What is the revenue of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
RAGHUVIR SYNTHETICS LTD. reported trailing-twelve-month revenue of about ₹2.1B (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For RAGHUVIR SYNTHETICS LTD. it is ₹8.36 per share (as of Oct 4, 2026), against a price of ₹65.50. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is RAGHUVIR SYNTHETICS LTD. stock overvalued or undervalued in 2026?
As of Oct 4, 2026, RAGHUSYN trades above its calculated fair value: price ₹65.50, fair value ₹8.36, a gap of about −87% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RAGHUSYN?
No. The price is what the market pays today (₹65.50); the fair value is what the company's own numbers justify (₹8.36). For RAGHUVIR SYNTHETICS LTD. the two are ₹57.14 per share apart. That gap is exactly why we show both numbers side by side.
How much is RAGHUVIR SYNTHETICS LTD. worth?
The market values RAGHUVIR SYNTHETICS LTD. at about ₹2.5B (market capitalisation, as of Oct 4, 2026). Per share that is ₹65.50; our models calculate a fair value of ₹8.36 per share.
What do the bullish and bearish scenarios say about RAGHUSYN?
Our models span a range for RAGHUVIR SYNTHETICS LTD.: cautious scenario ₹1.67, base ₹8.36, optimistic ₹15.04 per share (as of Oct 4, 2026, price ₹65.50). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
Balance-sheet figures for RAGHUVIR SYNTHETICS LTD. (as of Oct 4, 2026): return on equity −3.7%, debt of 0.70 per unit of equity. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is RAGHUSYN from its 52-week high?
RAGHUVIR SYNTHETICS LTD. trades at ₹65.50, about 45% below its 52-week high of ₹120.15 and at the low of ₹65.50 (as of Oct 19, 2026). Distance from the high says nothing about value: that is what the fair value of ₹8.36 is for.
Which stocks are comparable to RAGHUVIR SYNTHETICS LTD.?
From the same area (Consumer Discretionary) we also value RAJPALAYAM, LAKSHMIMIL, VTMLTD, OMNITEX, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is RAGHUVIR SYNTHETICS LTD. stock attractive at the current price?
The data as of Oct 4, 2026: price ₹65.50, calculated fair value ₹8.36 (−87%), Quality Score 41/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RAGHUSYN calculated?
We run RAGHUVIR SYNTHETICS LTD. through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹8.36, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. RAGHUVIR SYNTHETICS LTD. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
The closing price on Oct 19, 2026 was ₹65.50. Our model-based fair value is ₹8.36, about −87% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with RAGHUVIR SYNTHETICS LTD. right now?
The price sits above even our optimistic bull case (₹15.04). The favourable scenario is already priced in. Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (₹1.67 to ₹15.04). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of RAGHUVIR SYNTHETICS LTD.

How large is the market capitalisation of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
The market capitalisation of RAGHUVIR SYNTHETICS LTD. is ₹2.5B (≈ $26.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
The price-to-sales ratio of RAGHUVIR SYNTHETICS LTD. is 1.46 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
Earnings per share at RAGHUVIR SYNTHETICS LTD. are ₹−2.54. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
The net margin of RAGHUVIR SYNTHETICS LTD. is −4.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
The return on equity (ROE) of RAGHUVIR SYNTHETICS LTD. is −3.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
On an EBIT basis the return on assets of RAGHUVIR SYNTHETICS LTD. is 1.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
The operating margin of RAGHUVIR SYNTHETICS LTD. is −8.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
Revenue at RAGHUVIR SYNTHETICS LTD. is growing −56.4% versus a year earlier (3y avg +39.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at RAGHUVIR SYNTHETICS LTD. (RAGHUSYN)?
Earnings per share at RAGHUVIR SYNTHETICS LTD. are growing −55.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does RAGHUVIR SYNTHETICS LTD. (RAGHUSYN) generate?
The free cash flow of RAGHUVIR SYNTHETICS LTD. is −₹468M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does RAGHUVIR SYNTHETICS LTD. (RAGHUSYN) carry?
The net debt of RAGHUVIR SYNTHETICS LTD. is ₹712M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch RAGHUVIR SYNTHETICS LTD. in the live analysis

One click puts RAGHUVIR SYNTHETICS LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.